World Health Organization starts vaccination campaign in Iraq; Daiichi Sankyo recalls 8 vaccine lots;

> In an effort to contain a major cholera outbreak in Iraq, the World Health Organization has kick-started a campaign to vaccinate 255,000 people there against the illness within a month. Report

> Daiichi Sankyo recalled two lots of a freeze-dried live attenuated measles vaccine and 6 lots of a measles and rubella combined vaccine. Report

> TapImmune relocated its corporate headquarters from Seattle to Jacksonville, FL, to prepare for Phase II breast cancer vaccine trials next year in conjunction with the Mayo Clinic in Florida. Report

> Research published in The Journal of Infectious Diseases this week suggested that statins could negatively impact the protective qualities of flu vaccines. Report

> Saint Louis University received a $5.8 million National Institutes of Health contract for an "omics" research initiative into the safety and effectiveness of vaccines and other methods to combat infectious diseases. Release

Suggested Articles

With its phase 3 trial moving right along, Moderna is expecting efficacy data in November—likely after Pfizer and BioNTech, but before everyone else.

BioNTech expects a quick turnaround once the transaction closes and plans to produce up to 250 million doses of BNT162b2 in the first half of 2021.

Participation in clinical trials among Black people is low, FDA statistics show, even as drugmakers prioritize including them in COVID-19 shot trials.